ReNeuron Group PLC
LSE:RENE
ReNeuron Group PLC
Revenue
ReNeuron Group PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
R
|
ReNeuron Group PLC
LSE:RENE
|
Revenue
£250k
|
CAGR 3-Years
46%
|
CAGR 5-Years
38%
|
CAGR 10-Years
29%
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Revenue
$6.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Revenue
$1.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Revenue
$41.6m
|
CAGR 3-Years
55%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Revenue
£249.4m
|
CAGR 3-Years
102%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Revenue
£673.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
See Also
What is ReNeuron Group PLC's Revenue?
Revenue
250k
GBP
Based on the financial report for Sep 30, 2023, ReNeuron Group PLC's Revenue amounts to 250k GBP.
What is ReNeuron Group PLC's Revenue growth rate?
Revenue CAGR 10Y
29%
Over the last year, the Revenue growth was -68%. The average annual Revenue growth rates for ReNeuron Group PLC have been 46% over the past three years , 38% over the past five years , and 29% over the past ten years .